National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Glycopyrronium bromide (Sialanar®) is indicated for symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders

Rapid Review

Commenced Completed Outcome
07 March 2017 13 April 2017 Full pharmacoeconomic evaluation recommended at the submitted price